{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:45:02Z","timestamp":1766486702450,"version":"3.41.2"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Research and Development Project of China","award":["2021YFA1300500"],"award-info":[{"award-number":["2021YFA1300500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072694","82272625"],"award-info":[{"award-number":["82072694","82272625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Tumor polyvalent neoantigen mRNA vaccines are gaining prominence in immunotherapy. The design of sequences in vaccine development is crucial for enhancing both the immunogenicity and safety of vaccines. However, a major challenge lies in selecting the optimal sequences from the large pools generated by multiple peptide combinations and synonymous codons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We introduce NeoDesign, a computational tool designed to tackle the challenge of sequence design. NeoDesign comprises four modules: Library Construction, Optimal Path Filtering, Linker Addition, and \u03bb-Evaluation. It aims to identify the optimal protein sequence for tumor polyvalent neoantigen vaccines by minimizing linker usage, avoiding unexpected neoantigens and functional domains, and simplifying the structure. It also provides a preference scheme to balance mRNA stability and protein expression when designing mRNA sequences for the optimal protein sequence. This tool can potentially improve the sequence design of tumor polyvalent neoantigen mRNA vaccines, thereby significantly advancing immunotherapy strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>NeoDesign is freely available on https:\/\/github.com\/HuangLab-Fudan\/neoDesign and https:\/\/figshare.com\/projects\/NeoDesign\/221704.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btae585","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:20:28Z","timestamp":1727457628000},"source":"Crossref","is-referenced-by-count":2,"title":["NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations"],"prefix":"10.1093","volume":"40","author":[{"given":"Wenqian","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"given":"Hongwu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"given":"Jingjing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"given":"Hena","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"given":"Kalam","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"given":"Zhixiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-0794","authenticated-orcid":false,"given":"Shenglin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University , Shanghai 200032,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai 200032,","place":["China"]}]}],"member":"286","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"2024101317311526400_btae585-B1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity"},{"key":"2024101317311526400_btae585-B2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4161\/cc.4.8.1900","article-title":"p53 proteasomal degradation: poly-ubiquitination is not the whole story","volume":"4","author":"Asher","year":"2005","journal-title":"Cell Cycle"},{"key":"2024101317311526400_btae585-B3","first-page":"756","article-title":"Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA","volume":"15","author":"Asrani","year":"2018","journal-title":"RNA Biol"},{"key":"2024101317311526400_btae585-B4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","article-title":"Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer","volume":"40","author":"Awad","year":"2022","journal-title":"Cancer Cell"},{"key":"2024101317311526400_btae585-B5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jmb.2008.12.081","article-title":"Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination","volume":"386","author":"Baugh","year":"2009","journal-title":"J Mol Biol"},{"key":"2024101317311526400_btae585-B6","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/s41467-022-31657-x","article-title":"The mechanism of replication stalling and recovery within repetitive DNA","volume":"13","author":"Casas-Delucchi","year":"2022","journal-title":"Nat Commun"},{"key":"2024101317311526400_btae585-B7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature04530","article-title":"Endonucleolytic cleavage of eukaryotic mrnas with stalls in translation elongation","volume":"440","author":"Doma","year":"2006","journal-title":"Nature"},{"key":"2024101317311526400_btae585-B8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/vaccines8040776","article-title":"Neo-antigen mRNA vaccines","volume":"8","author":"Esprit","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"2024101317311526400_btae585-B9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10528-006-9059-5","article-title":"Relationship between mRNA stability and length: An old question with a new twist","volume":"45","author":"Feng","year":"2007","journal-title":"Biochem Genet"},{"key":"2024101317311526400_btae585-B10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fimmu.2019.01392","article-title":"Determinants for neoantigen identification","volume":"10","author":"Garcia-Garijo","year":"2019","journal-title":"Front Immunol"},{"key":"2024101317311526400_btae585-B11","doi-asserted-by":"crossref","first-page":"bbad001","DOI":"10.1093\/bib\/bbad001","article-title":"Integrated mRNA sequence optimization using deep learning","volume":"24","author":"Gong","year":"2023","journal-title":"Brief Bioinform"},{"key":"2024101317311526400_btae585-B12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41587-023-01945-y","article-title":"Systematic discovery of neoepitope\u2013HLA pairs for neoantigens shared among patients and tumor types","volume":"42","author":"Gurung","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2024101317311526400_btae585-B13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/2326-6066.CIR-13-0022","article-title":"Getting personal with neoantigen-based therapeutic cancer vaccines","volume":"1","author":"Hacohen","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"2024101317311526400_btae585-B14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumor-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2024101317311526400_btae585-B15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","article-title":"pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens","volume":"8","author":"Hundal","year":"2016","journal-title":"Genome Med"},{"key":"2024101317311526400_btae585-B16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: a computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"2024101317311526400_btae585-B17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/emm.2007.74","article-title":"DNA vaccines for cervical cancer: from bench to bedside","volume":"39","author":"Hung","year":"2007","journal-title":"Exp Mol Med"},{"key":"2024101317311526400_btae585-B18","doi-asserted-by":"crossref","first-page":"e1561106","DOI":"10.1080\/2162402X.2018.1561106","article-title":"Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma","volume":"8","author":"Johanns","year":"2019","journal-title":"Oncoimmunology"},{"key":"2024101317311526400_btae585-B19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.cell.2015.04.017","article-title":"Mitochondrial ClpX activates a key enzyme for heme biosynthesis and erythropoiesis","volume":"161","author":"Kardon","year":"2015","journal-title":"Cell"},{"key":"2024101317311526400_btae585-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol Cell Toxicol"},{"key":"2024101317311526400_btae585-B21","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.3389\/fmicb.2018.02738","article-title":"Proteasomal degradation machinery: favorite target of HIV-1 proteins","volume":"9","author":"Lata","year":"2018","journal-title":"Front Microbiol"},{"key":"2024101317311526400_btae585-B22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41467-022-28776-w","article-title":"Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics","volume":"13","author":"Leppek","year":"2022","journal-title":"Nat Commun"},{"key":"2024101317311526400_btae585-B23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrm.2017.103","article-title":"Functional 5\u2019 UTR mRNA structures in eukaryotic translation regulation and how to find them","volume":"19","author":"Leppek","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2024101317311526400_btae585-B24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat Cancer"},{"key":"2024101317311526400_btae585-B25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"2024101317311526400_btae585-B26","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10238-023-01020-5","article-title":"RNA modification in mRNA cancer vaccines","volume":"23","author":"Mei","year":"2023","journal-title":"Clin Exp Med"},{"key":"2024101317311526400_btae585-B27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molcel.2012.05.049","article-title":"A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1","volume":"47","author":"Moscovitz","year":"2012","journal-title":"Mol Cell"},{"key":"2024101317311526400_btae585-B28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics"},{"key":"2024101317311526400_btae585-B29","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.3390\/cancers14205163","article-title":"Neoantigen vaccines; clinical trials, classes, indications, adjuvants, and combinatorial treatments","volume":"14","author":"Niemi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024101317311526400_btae585-B30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: Improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O\u2019Donnell","year":"2020","journal-title":"Cell Syst"},{"key":"2024101317311526400_btae585-B31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"2024101317311526400_btae585-B32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2024101317311526400_btae585-B33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: An emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol Cancer"},{"key":"2024101317311526400_btae585-B34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nsmb1122","article-title":"Proteasome-mediated protein processing by bidirectional degradation initiated from an internal site","volume":"13","author":"Piwko","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"2024101317311526400_btae585-B35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/nsmb814","article-title":"An unstructured initiation site is required for efficient proteasome-mediated degradation","volume":"11","author":"Prakash","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"2024101317311526400_btae585-B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/nar\/gkaa1182","article-title":"Basic mechanisms and kinetics of pause-interspersed transcript elongation","volume":"49","author":"Qian","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2024101317311526400_btae585-B37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.immuni.2023.03.009","article-title":"Machine learning predictions of MHC-II specificities reveal alternative binding modes of class II epitopes","volume":"56","author":"Racle","year":"2023","journal-title":"Immunity"},{"key":"2024101317311526400_btae585-B38","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2024101317311526400_btae585-B39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumor-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2024101317311526400_btae585-B40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/440425a","article-title":"RNA lost in translation","volume":"440","author":"Tollervey","year":"2006","journal-title":"Nature"},{"key":"2024101317311526400_btae585-B41","doi-asserted-by":"crossref","first-page":"bbad116","DOI":"10.1093\/bib\/bbad116","article-title":"TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning","volume":"24","author":"Wang","year":"2023","journal-title":"Brief Bioinform"},{"key":"2024101317311526400_btae585-B42","doi-asserted-by":"crossref","first-page":"583193","DOI":"10.3389\/fimmu.2020.583193","article-title":"Insight into inflammasome signaling: implications for Toxoplasma gondii infection","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"2024101317311526400_btae585-B43","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1093\/bioinformatics\/btab628","article-title":"pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification","volume":"37","author":"Weeder","year":"2021","journal-title":"Bioinformatics"},{"key":"2024101317311526400_btae585-B44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/pro.3243","article-title":"Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display","volume":"26","author":"Wei","year":"2017","journal-title":"Protein Sci"},{"key":"2024101317311526400_btae585-B45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2024101317311526400_btae585-B46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumor mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"2024101317311526400_btae585-B47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","article-title":"Algorithm for optimized mRNA design improves stability and immunogenicity","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btae585\/59380110\/btae585.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/10\/btae585\/59738875\/btae585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/10\/btae585\/59738875\/btae585.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T17:32:04Z","timestamp":1728840724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btae585\/7781681"}},"subtitle":[],"editor":[{"given":"Anthony","family":"Mathelier","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btae585","relation":{},"ISSN":["1367-4811"],"issn-type":[{"type":"electronic","value":"1367-4811"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,27]]},"article-number":"btae585"}}